New Gen4 Suit Offers Enhanced Design, Optimal Fit, and Superior Durability
LAS VEGAS, Nov. 13, 2024 /PRNewswire/ — Katalyst, the leader in Electro Muscle Stimulation (EMS) fitness, today announced the Gen4 Suit, the latest evolution of its award-winning product, reaffirming its commitment to making strength training easier, faster, safer, and more effective for everyone.
The Gen4 Suit builds on Katalyst’s success in EMS fitness technology, offering advancements in design, fit, and durability, to continuously improve the user experience.
“With hundreds of thousands of workouts completed on our platform to date, we’ve gained valuable insights into how our customers use Katalyst at home, on the road, and in commercial settings,” said Bjoern Woltermann, Founder and CEO of Katalyst. “With Gen4, we’re delivering an even more convenient, personalized, and premium fitness experience.”
A Revolution in High-Efficiency Workouts
Named one of Time Magazine’s Best Inventions of 2023, Katalyst uses EMS technology to deliver a full-body workout that engages up to 90% of muscles in only 20 minutes. Through the Katalyst App, users can access hundreds of strength, power, cardio, and recovery workouts, as well as expert-crafted workout programs to reach specific goals, providing a complete training solution with zero impact on the musculoskeletal system.
The Katalyst Gen4 Suit is now available on Katalyst.com for $2,499 with membership plans starting as low as $29/month.
Media assets are available here.
About Katalyst
Katalyst makes working out easier, faster, safer, and more effective than ever before. Combining advanced Electro Muscle Stimulation (EMS) technology with trainer-led, in-app workouts, the full-body EMS Suit directly activates up to 90% of muscles in just 20 minutes, improving strength without weights or wear-and-tear on your body. Katalyst is the only full-body EMS device that is FDA-cleared for at-home consumer use.
Get in touch: press@katalyst.com
SOURCE Katalyst
LANCASTER, Calif., May 15, 2025 /PRNewswire/ -- Legacy Education Inc. (NYSE American: LGCY), a leading…
Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW…
SAN FRANCISCO, May 15, 2025 /PRNewswire/ -- MediKarma, a digital health company specializing in AI-powered…
BOSTON, May 15, 2025 /PRNewswire/ -- Dentegrate AI is revolutionizing dental practice growth, with over…
Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating…
Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May…